Ace the Cough Reflex Test 2025 – Boost Your Respiratory Skills Today!

When a patient receiving nebulizer treatment with 3% saline reports shortness of breath, discontinuing the therapy and notifying the physician is the most appropriate action. It is essential to prioritize patient safety and responsive care in situations where a patient exhibits distress or adverse reactions. Shortness of breath can indicate that the patient is experiencing complications from the treatment, such as bronchospasm or irritation, which could be exacerbated by the saline solution.

By discontinuing the nebulizer treatment, the respiratory therapist can prevent further distress and reassess the situation. Notifying the physician allows for a collaborative approach to address the patient's symptoms and decide on the next steps, which may include alternative treatments or evaluations of the patient's condition. This protocol ensures that the patient receives appropriate management based on their immediate needs and reactions to the current therapy.